Comment
doi: 10.1002/hep.28533.
Epub 2016 Apr 18.
Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a
Affiliations
- PMID: 26945900
- PMCID: PMC5042047
- DOI: 10.1002/hep.28533
Item in Clipboard
Comment
Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a
Hepatology.
2016 Oct.
No abstract available
Comment in
-
Reply.Hepatology. 2016 Oct;64(4):1378-9. doi: 10.1002/hep.28536. Epub 2016 Apr 15. Hepatology. 2016. PMID: 26946328 No abstract available.
Comment on
-
Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.Hepatology. 2016 Jan;63(1):63-73. doi: 10.1002/hep.28255. Epub 2015 Nov 25. Hepatology. 2016. PMID: 26406534
Similar articles
-
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy.PLoS One. 2015 Sep 14;10(9):e0138060. doi: 10.1371/journal.pone.0138060. eCollection 2015. PLoS One. 2015. PMID: 26368554 Free PMC article.
-
Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing.J Gastroenterol. 2016 Mar;51(3):260-70. doi: 10.1007/s00535-015-1106-8. Epub 2015 Aug 6. J Gastroenterol. 2016. PMID: 26245700
-
Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes.Elife. 2019 Sep 3;8:e42542. doi: 10.7554/eLife.42542. Elife. 2019. PMID: 31478832 Free PMC article.
-
The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay.J Gastroenterol. 2016 Jan;51(1):63-70. doi: 10.1007/s00535-015-1080-1. Epub 2015 Apr 24. J Gastroenterol. 2016. PMID: 25904097
-
Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C.Virol J. 2017 Aug 24;14(1):164. doi: 10.1186/s12985-017-0826-1. Virol J. 2017. PMID: 28836992 Free PMC article.
Cited by
-
Evolutionary Analysis Provides Insight Into the Origin and Adaptation of HCV.Front Microbiol. 2018 May 1;9:854. doi: 10.3389/fmicb.2018.00854. eCollection 2018. Front Microbiol. 2018. PMID: 29765366 Free PMC article.
-
Impact of Interferon Lambda 4 Genotype on Interferon-Stimulated Gene Expression During Direct-Acting Antiviral Therapy for Hepatitis C.Hepatology. 2018 Sep;68(3):859-871. doi: 10.1002/hep.29877. Hepatology. 2018. PMID: 29534310 Free PMC article. Clinical Trial.
-
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus.Nat Genet. 2017 May;49(5):666-673. doi: 10.1038/ng.3835. Epub 2017 Apr 10. Nat Genet. 2017. PMID: 28394351 Free PMC article.
References
-
- Peiffer KH, Sommer L, Susser S, Vermehren J, Herrmann E, Doring M, et al. Interferon lambda 4 genotypes and resistance‐associated variants in patients infected with hepatitis C virus genotypes 1 and 3. Hepatology 2016;63:63‐73. - PubMed
-
- Foster GR, Pianko S, Brown A, Forton D, Nahass RG, George J, et al. Efficacy of sofosbuvir plus ribavirin with or without peginterferon‐alfa in patients with hepatitis C virus genotype 3 infection and treatment‐experienced patients with cirrhosis and hepatitis C virus genotype 2 infection. Gastroenterology 2015;149:1462‐1470. - PubMed
-
- Bonsall D, Ansari M, Ip C, Trebes A, Brown A, Klenerman P, et al. ve‐SEQ: robust, unbiased enrichment for streamlined detection and whole‐genome sequencing of HCV and other highly diverse pathogens [version 1; referees: 1 approved]. 2015. Available at: http://f1000research.com/articles/4-1062/v1. Accessed on March 17, 2016. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
